Mumbai: Lupin Manufacturing Solutions, a subsidiary of global pharma major Lupin has announced a long-term strategic alliance with PolyPeptide Group AG, a specialized, global CDMO for peptide-based active pharmaceutical ingredients. This collaboration aims to enhance supply chain resilience, improve operational efficiency, and accelerate readiness for the rapidly expanding global peptides market. It also advances next-generation peptide therapeutics, including those for metabolics, supporting the long-term strategic growth of both organizations. As part of the alliance, both companies will work towards the following:  Expanding sourcing options and fortifying peptide supply chains to meet rising global demand for peptide APIs, including for metabolic disease therapies.  Integra

See Full Page